atenolol has been researched along with Autoimmune Diabetes in 10 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine patients with Type I diabetes mellitus, diastolic blood pressure of 90 to 100 mmHg and persistent microalbuminuria of greater than or equal to 30 micrograms/min were treated with 50 to 100 mg atenolol daily for 3 years in an uncontrolled pilot study to assess the effect of long-term reduction of blood pressure on microalbuminuria." | 7.68 | Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients. ( Davies, JA; Stickland, M; Tindall, H; Urquhart, S, 1991) |
| "The aim of the study was to evaluate the efficacy of enalapril and atenolol in decreasing the severity of proteinuria in hypertensive patients suffering from insulin-dependent diabetes mellitus." | 5.07 | Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients. ( Andriani, A; Bonfantino, MV; De Cesaris, R; Filitti, V; Ranieri, G, 1993) |
| "Nine patients with Type I diabetes mellitus, diastolic blood pressure of 90 to 100 mmHg and persistent microalbuminuria of greater than or equal to 30 micrograms/min were treated with 50 to 100 mg atenolol daily for 3 years in an uncontrolled pilot study to assess the effect of long-term reduction of blood pressure on microalbuminuria." | 3.68 | Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients. ( Davies, JA; Stickland, M; Tindall, H; Urquhart, S, 1991) |
| "We studied 49 patients with type 1 diabetes (age 50." | 2.73 | Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. ( Crea, F; Ghirlanda, G; Infusino, F; Lanza, GA; Manto, A; Musella, T; Navarese, EP; Pitocco, D; Sestito, A; Sgueglia, GA, 2007) |
| "The progression of diabetic nephropathy can be positively influenced by maintaining a low blood pressure level." | 2.67 | Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. ( Berden, JH; de Nobel, E; Elving, LD; van Lier, HJ; Wetzels, JF, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SP | 1 |
| Harris, ND | 1 |
| Robinson, RT | 1 |
| Davies, C | 1 |
| Ireland, R | 1 |
| Macdonald, IA | 1 |
| Heller, SR | 1 |
| Baumgart, P | 1 |
| Lanza, GA | 1 |
| Pitocco, D | 1 |
| Navarese, EP | 1 |
| Sestito, A | 1 |
| Sgueglia, GA | 1 |
| Manto, A | 1 |
| Infusino, F | 1 |
| Musella, T | 1 |
| Ghirlanda, G | 1 |
| Crea, F | 1 |
| De Cesaris, R | 1 |
| Ranieri, G | 1 |
| Filitti, V | 1 |
| Andriani, A | 1 |
| Bonfantino, MV | 1 |
| Hardy, KJ | 1 |
| Elving, LD | 1 |
| Wetzels, JF | 1 |
| van Lier, HJ | 1 |
| de Nobel, E | 1 |
| Berden, JH | 1 |
| Levinson, PD | 1 |
| Benn, JJ | 1 |
| Brown, PM | 1 |
| Beckwith, LJ | 1 |
| Farebrother, M | 1 |
| Sönksen, PH | 1 |
| Tindall, H | 2 |
| Urquhart, S | 1 |
| Stickland, M | 1 |
| Davies, JA | 2 |
| Hopper, AH | 1 |
1 review available for atenolol and Autoimmune Diabetes
| Article | Year |
|---|---|
Beta-blockers, diabetes, and hypoglycemia: risky business?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aten | 2001 |
3 trials available for atenolol and Autoimmune Diabetes
| Article | Year |
|---|---|
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atenolol; Autonomic Nervous System Diseases; C-Re | 2007 |
Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients.
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; Diabetic Neph | 1993 |
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephrop | 1994 |
6 other studies available for atenolol and Autoimmune Diabetes
| Article | Year |
|---|---|
Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Diabetes Mellitus, Type 1; Electrocardiograph | 2005 |
[Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2006 |
Antihypertensives retarding progression of diabetic nephropathy.
Topics: Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans | 1995 |
Glucose turnover in type I diabetic subjects during exercise. Effect of selective and nonselective beta-blockade and insulin withdrawal.
Topics: Adult; Atenolol; Betaxolol; Blood Glucose; Diabetes Mellitus, Type 1; Exercise; Glucose; Glycated He | 1992 |
Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephro | 1991 |
The course of incipient diabetic nephropathy.
Topics: Adult; Albuminuria; Atenolol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Middle Aged | 1986 |